---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-270039"
form_type: "8-K"
ticker: "PCVX"
cik: "0001649094"
company_name: "Vaxcyte, Inc."
filed_at: "2022-10-27T23:59:59+00:00"
generated_at: "2026-06-23T00:04:30.884296+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Vaxcyte prices $650.7M underwritten public offering of common stock and pre-funded warrants

## Summary
- Selling 15M shares at $32.00/share and pre-funded warrants for 3.75M shares at $31.999 each.
- Underwriters exercised option to purchase additional 2,812,500 shares; net proceeds expected ~$650.7M.
- Closing expected October 28, 2022, subject to customary closing conditions.
- Underwriting agreement filed as Exhibit 1.1; pre-funded warrant form filed as Exhibit 4.1.

## SEC filing metadata
- accession: 0001193125-22-270039
- form_type: 8-K
- ticker: PCVX
- cik: 0001649094
- company_name: Vaxcyte, Inc.
- filed_at: 2022-10-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1649094/000119312522270039/0001193125-22-270039-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1649094/000119312522270039/d374961d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-270039
- JSON: https://secwatch.observer/filing/0001193125-22-270039.json
- Plain text: https://secwatch.observer/filing/0001193125-22-270039.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.